The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer

Diseases of the Colon and Rectum

Volumn 50, Issue 11, 2007, Pages 1873-1880

  Kwak, Jung Myun ^a   Min, Byung Wook ^a,b   Lee, Ju Han ^a   Choi, Jong Sang ^a   Lee, Sun Il ^a   Park, Sung Soo ^a   Kim, Jin ^a   Um, Jun Won ^a   Kim, Seon Han ^a   Moon, Hong Young ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

Colorectal cancer; E cadherin; Immunohistochemistry; Liver intestine cadherin; Overall survival; Potential marker

Indexed keywords

CADHERIN; UVOMORULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; COLORECTAL CANCER; CONFIDENCE INTERVAL; FEMALE; HAZARD RATIO; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR CELL;

AGED; CADHERINS; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 35948934669     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-007-9034-1     Document Type: Article

References (29)

1. Okegawa T, Pong RC, Li Y, Hsieh JT. The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol 2004;51:445-457.
2. Angst BD, Marcozzi C, Magee AI. The cadherin superfamily: diversity in form and function. J Cell Sci 2001;114:629-641.
3. Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988;102:639-655.
4. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995;7:619-627.
5. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998;153:333-339.
6. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-357.
7. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-1455.
8. Jawhari A, Farthing M, Pignatelli M. The importance of the E-cadherin-catenin complex in the maintenance of intestinal epithelial homoeostasis: more than intercellular glue? Gut 1997;41:581-584.
9. Okegawa T, Li Y, Pong RC, Hsieh JT. Cell adhesion proteins as tumor suppressors. J Urol 2002;167:1836-1843.
10. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-1701.
11. Joo YE, Park CS, Kim HS, Choi SK, Rew JS, Kim SJ. Prognostic significance of E-cadherin/catenin complex expression in gastric cancer. J Korean Med Sci 2000;15:655-666.
12. Ghadimi BM, Behrens J, Hoffmann I, Haensch W, Birchmeier W, Schlag PM. Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer 1999;35:60-65.
13. Choi YS, Shim YM, Kim SH, et al. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2003;24:441-449.
14. Morita N, Uemura H, Tsumatani K, et al. E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion. Br J Cancer 1999;79:1879-83.
15. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-811.
16. Berndorff D, Gessner R, Kreft B, et al. Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine. J Cell Biol 1994;125:1353-1369.
17. Kreft B, Berndorff D, Bottinger A, et al. LI-cadherin-mediated cell-cell adhesion does not require cytoplasmic interactions. J Cell Biol 1997;136:1109-1121.
18. Grotzinger C, Kneifel J, Patschan D, et al. LI-cadherin: a marker of gastric metaplasia and neoplasia. Gut 2001;49:73-81.
19. Hinoi T, Lucas PC, Kuick R, Hanash S, Cho KR, Fearon ER. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 2002;123:1565-1577.
20. Wong BW, Luk JM, Ng IO, Hu MY, Liu KD, Fan ST. Identification of liver-intestine cadherin in hepatocellular carcinoma-a potential disease marker. Biochem Biophys Res Commun 2003;311:618-624
21. Takamura M, Sakamoto M, Ino Y, et al. Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci 2003;94:425-430.
22. Takamura M, Ichida T, Matsuda Y, et al. Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma. Cancer Lett 2004;212:253-259.
23. Gessner R, Tauber R. Intestinal cell adhesion molecules. Liver-intestine cadherin. Ann N Y Acad Sci 2000;915:136-143.
24. Hortsch M, Wang YM, Marikar Y, Bieber AJ. The cytoplasmic domain of the Drosophila cell adhesion molecule neuroglian is not essential for its hemophilic adhesive properties in S2 cells. J Biol Chem 1995;270:18809-18817.
25. Ilyas M, Tomlinson IP. The interactions of APC, E-cadherin and beta-catenin in tumour development and progression. J Pathol 1997;182:128-137.
26. Ikeguchi M, Makino M, Kaibara N. Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma. J Surg Oncol 2001;77:201-207.
27. Kitagawa T, Matsumoto K, Nagafuchi A, Tsukita S, Suzuki H. Co-expression of E-cadherin and alpha-catenin molecules in colorectal cancer. Surg Today 1999;29:511-518.
28. Hugh TJ, Dillon SA, Taylor BA, Pignatelli M, Poston GJ, Kinsella AR. Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer 1999;80:1046-1051.
29. Ko S, Chu KM, Luk JM et al. Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis. Biochem Biophys Res Commun 2004;319:562-568.